| 000 | 01895 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516100504.0 | ||
| 264 | 0 | _c20130603 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1752-8984 | ||
| 024 | 7 |
_a10.1177/1479164112449562 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIrace, Concetta | |
| 245 | 0 | 0 |
_aExenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research. _h[electronic resource] |
| 260 |
_bDiabetes & vascular disease research _cJan 2013 |
||
| 300 |
_a72-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Flow Velocity _xphysiology |
| 650 | 0 | 4 |
_aBrachial Artery _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdiagnostic imaging |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aExenatide |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Glucagon _xagonists |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aUltrasonography, Doppler |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 |
_aVenoms _xtherapeutic use |
| 700 | 1 | _aDe Luca, Simona | |
| 700 | 1 | _aShehaj, Ermal | |
| 700 | 1 | _aCarallo, Claudio | |
| 700 | 1 | _aLoprete, Antonio | |
| 700 | 1 | _aScavelli, Faustina | |
| 700 | 1 | _aGnasso, Agostino | |
| 773 | 0 |
_tDiabetes & vascular disease research _gvol. 10 _gno. 1 _gp. 72-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1479164112449562 _zAvailable from publisher's website |
| 999 |
_c21893305 _d21893305 |
||